Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts

NCT04399577 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT04399577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04399577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts
Lead sponsor
Zagazig University
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2017
Completion date
September 3, 2019
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

warts